The IN VIVO Blog

Pages

▼
Showing posts with label secondary offerings. Show all posts
Showing posts with label secondary offerings. Show all posts
Friday, November 15, 2013

Financings Of The Fortnight Does Bollywood On A Budget

›
With IPOs still the twitter, er, talk of the town, the relative lack thereof the past couple weeks in our little corner of the world was not...
Friday, May 31, 2013

Financings of the Fortnight Battles the Bull Run

›
Since when did biotech’s epicenter move to Pamplona? The bull run has lasted quite a while now, after having gotten an extra goose, if yo...
Friday, July 13, 2012

Financings of the Fortnight Follows the Follow-Ons

›
The half-year data are in. Public biopharma firms raised $3.14 billion in secondary offerings through the end of June. According to Els...
›
Home
View web version

Contributors

  • Adam Gordon
  • Alex Lash
  • Amanda Micklus
  • Chris Morrison
  • Chris Trudeau
  • John Davis
  • Joseph Haas
  • Lisa LaMotta
  • M. Nielsen Hobbs
  • Mark Ratner
  • Mary Jo Laffler
  • Michael Goodman
  • Scott Steinke
  • Sten Stovall
  • Tom Salemi
  • Unknown
  • Unknown
  • Unknown
  • Wendy Diller
Powered by Blogger.